Economic effectiveness of disease management programs: a meta-analysis.
The economic effectiveness of disease management programs, which are designed to improve the clinical and economic outcomes for chronically ill individuals, has been evaluated extensively. A literature search was performed with MEDLINE and other published sources for the period covering January 1995 to September 2003. The search was limited to empirical articles that measured the direct economic outcomes for asthma, diabetes, and heart disease management programs. Of the 360 articles and presentations evaluated, only 67 met the selection criteria for meta-analysis, which included 32,041 subjects. Although some studies contained multiple measurements of direct economic outcomes, only one average effect size per study was included in the meta-analysis. Based on the studies included in the research, a meta-analysis provided a statistically significant answer to the question of whether disease management programs are economically effective. The magnitude of the observed average effect size for equally weighted studies was 0.311 (95% CI = 0.272-0.350). Statistically significant differences of effect sizes by study design, disease type and intensity of disease management program interventions were not found after a moderating variable, disease severity, was taken into consideration. The results suggest that disease management programs are more effective economically with severely ill enrollees and that chronic disease program interventions are most effective when coordinated with the overall level of disease severity. The findings can be generalized, which may assist health care policy makers and practitioners in addressing the issue of providing economically effective care for the growing number of individuals with chronic illness.
Krause
David S
DS
Department of Finance, College of Business Administration, Marquette University, Milwaukee, Wisconsin 53201-1881, USA. david.krause@marquette.edu
D000704:Analysis of Variance; D002908:Chronic Disease / Q000191:economics / Q000628:therapy*; D003362:Cost-Benefit Analysis; D019468:Disease Management; D006801:Humans; D016014:Linear Models; D017063:Outcome Assessment, Health Care; D010346:Patient Care Management / Q000191:economics*